The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Open accessAbstract
Cholangiocarcinoma (CCA) is an epithelial cancer originating from the bile ducts with features of cholangiocyte differentiation.1 CCA is the second most common primary hepatic malignancy, and epidemiologic studies suggest its incidence is increasing in Western countries.2 Advanced CCA has a devastating prognosis, with a median survival of <24 months.3 The only curative therapy is surgical extirpation or liver transplantation, but unfortunately the majority of patients present with advanced stage disease, which is not amenable to surgical therapies. Anatomically, CCA is classified into extrahepatic and intrahepatic forms of the disease. The extrahepatic form is more common, accounting for 80% to 90% of CCAs. It is further divided into proximal or perihilar and distal subsets depending on the location of the cancer within the extrahepatic biliary system. Perihilar disease is also frequently referred to as a Klatskin tumor. Three different growth patterns of extrahepatic CCA can be observed: (1) periductal infiltrating, (2) papillary or intraductal, and (3) mass forming.4 Intrahepatic CCA typically presents as an intrahepatic mass. In addition to their distinct morphology and clinical presentations, intrahepatic and extrahepatic CCAs differ in etiopathogenesis, molecular signatures, and management. In the last several years there have been significant new insights into the molecular pathogenesis of CCA. New diagnostic and therapeutic modalities have also been developed, resulting in improved detection rates and outcomes. In addition, we have now entered the era of targeted therapies for human cancers. Therefore, it is timely and topical to review these advances with a focus on promising targeted therapies for this disease. An additional goal is to stimulate further interest in this disease with the hope of improving outcomes for this still highly lethal malignancy. Hepatobiliary malignancies account for 13% of the 7.6 million annual cancer-related deaths worldwide and for 3% of the 560,000 annual cancer-related deaths in the United States. CCA accounts for 10% to 20% of the deaths from hepatobiliary malignancies. The prevalence of CCA shows a wide geographic variability, with the highest rates in Asia and the lowest in Australia.5 In the United States, the incidence of CCA has been reported to be 0.95/100,000 for intrahepatic forms and 0.82/100,000 for extrahepatic forms of the disease.5 Its prevalence in different racial and ethnic groups is heterogeneously distributed, with the highest age-adjusted prevalence in Hispanics (1.22/100,000) and the lowest in African Americans (0.17-0.5/100,000).6 In the last 4 decades, United States incidence rates of intrahepatic CCA have increased by 165%, whereas the extrahepatic CCA incidence has remained stable.7, 8 The significant increase in age-adjusted incidence of intrahepatic CCA was confirmed after correction for a prior misclassification of hilar CCA as intrahepatic CCA.2 Similarly, increasing incidence rates of intrahepatic CCA have also been reported in Western Europe and Japan.9, 10 The cause for the increasing incidence has not been identified. We speculate that increased lipid mediators such as oxysterols may contribute to the current increased incidence in Western societies.11 In Western nations, the median age at presentation is >65 years, and it is only rarely diagnosed in patients <40 years of age except in patients with primary sclerosing cholangitis (PSC).5 There is a slight male predominance for CCA. CCA, cholangiocarcinoma; CT, computed tomography; DIA, digital image analysis; EGFR, epidermal growth factor receptor; ERCP, endoscopic retrograde cholangiopancreatography; FISH, fluorescence in situ hybridization; IL-6, interleukin-6; iNOS, inducible nitric oxide synthase; MAPK, mitogen-activated protein kinase; MRCP, magnetic resonance cholangiopancreatography; MRI, magnetic resonance imaging; PDT, photodynamic therapy; PET, positron emission tomography; PSC, primary sclerosing cholangitis; PTC, percutaneous transhepatic cholangiography; RNOS, reactive nitrogen oxide species; TRAIL, tumor necrosis factor–related apoptosis-inducing ligand. In the majority of cases, the etiology of CCA remains obscure. However, several conditions associated with inflammation and cholestasis have been identified as risk factors for CCA (Table 1). PSC is a common risk factor. The prevalence of CCA in this condition is 5% to 15%, and the annual incidence rate is 0.6% to 1.5%.12, 13 The majority of PSC patients who develop CCA do so within the first 2.5 years following the diagnosis of PSC.12, 13 Thus, the symptomatic patient who presents with their first diagnosis of PSC should be carefully screened for CCA. Hepatobiliary flukes—especially the species Opisthorchis viverrini and Clonorchis sinenesis—are risk factors for CCA.14 They are endemic in portions of East Asia, where ingesting undercooked fish is common. Several case–control studies as well as animal models have confirme
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Han, C. L., & Wu, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500562200 · Cited by 153
RetractedSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
Jarnagin, W. R., Fong, Y., DeMatteo, R. P., Gonen, M., Burke, E. C., Bodniewicz, J., Youssef, M., Klimstra, D., & Blumgart, L. H. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00010 · Cited by 1,347
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
The Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
MAKUUCHI, M., Thai, B. L., Takayasu, K., Takayama, T., Kosuge, T., Gunvén, P., Yamazaki, S., Hasegawa, H., & Ozaki, H. (1990) · PubMed · Cited by 1,120
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
de Groen, P. C., Gores, G. J., LaRusso, N. F., Gunderson, L. L., & Nagorney, D. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411807 · Cited by 955
Self-citationThe role of IL-6 and STAT3 in inflammation and cancer
Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 950
Johnson, J. I., Decker, S., Zaharevitz, D., Rubinstein, L. V., Venditti, J. M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1796 · Cited by 856
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834
Self-citationSmith, A. C., Dowsett, J. F., Russell, R. C. G., Hatfield, A. R., & Cotton, P. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90455-3 · Cited by 824
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Rea, D. J., Heimbach, J. K., Rosen, C. B., Haddock, M. G., Alberts, S. R., Kremers, W. K., Gores, G. J., & Nagorney, D. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179678.13285.fa · Cited by 693
Self-citationRising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
Shaib, Y. H., Davila, J. A., McGlynn, K., & El-Serag, H. B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.030 · Cited by 683
Extended Resections for Hilar Cholangiocarcinoma
Neuhaus, P., Jonas, S., Bechstein, W. O., Lohmann, R., Radke, C., Kling, N., Wex, C., Lobeck, H., & Hintze, R. (1999) · Annals of Surgery · doi:10.1097/00000658-199912000-00010 · Cited by 675
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Bélec, L., Billot, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709443104 · Cited by 659
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Self-citationGuidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
Khan, S. A., Davidson, B. R., Goldin, R., Pereira, S. P., Rosenberg, W. M. C., Taylor-Robinson, S. D., Thillainayagam, A. V., Thomas, H. C., Thursz, M. R., & Wasan, H. (2002) · Gut · doi:10.1136/gut.51.suppl_6.vi1 · Cited by 648
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study
Ortner, M. E. J., Caca, K., Berr, F., Liebetruth, J., Mansmann, U., Huster, D., Voderholzer, W., Schachschal, G., Mössner, J., & Lochs, H. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.015 · Cited by 608
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
Shepherd, H. A., Royle, G. T., Ross, A. P. R., Diba, A., Arthur, M. J. P., & Colin-Jones, D. G. (1988) · British journal of surgery · doi:10.1002/bjs.1800751207 · Cited by 542
Nagino, M., Kamiya, J., Nishio, H., Ebata, T., Arai, T., & Nimura, Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201482.11876.14 · Cited by 540
(2003) · PubMed · Cited by 523
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
Meyer, C. G., Penn, I., & James, L. (2000) · Transplantation · doi:10.1097/00007890-200004270-00019 · Cited by 502
Abdalla, E. K. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.6.675 · Cited by 489
Kaassis, M., Boyer, J., Dumas, R., Ponchon, T., Coumaros, D., Delcenserie, R., Canard, J. M., Fritsch, J., Rey, J., & Burtin, P. C. (2003) · Gastrointestinal Endoscopy · doi:10.1067/mge.2003.66 · Cited by 471
Burke, E. C., Jarnagin, W. R., Hochwald, S. N., Pisters, P. W. T., Fong, Y., & Blumgart, L. H. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00011 · Cited by 468
Liver Transplantation for Malignant Disease: Results in 93 Consecutive Patients
OʼGRADY, J. G., POLSON, R. J., ROLLES, K., CALNE, R. Y., & WILLIAMS, R. (1988) · Annals of Surgery · doi:10.1097/00000658-198804000-00002 · Cited by 446
Patel, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00744-3 · Cited by 425
De Vreede, I., Steers, J. L., Burch, P. A., Rosen, C. B., Gunderson, L. L., Haddock, M. G., Burgart, L., & Gores, G. J. (2000) · Liver Transplantation · doi:10.1053/lv.2000.6143 · Cited by 395
Self-citationWelzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., & Pfeiffer, R. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj234 · Cited by 372
Palliation of Nonresectable Bile Duct Cancer: Improved Survival After Photodynamic Therapy
Zoepf, T., Jakobs, R., Arnold, J. C., Apel, D., & Riemann, J. F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00318.x · Cited by 356
Contributions of Human Tumor Xenografts to Anticancer Drug Development
Sausville, E. A., & Burger, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3627 · Cited by 348
Levy, C., Lymp, J., Angulo, P., Gores, G. J., Larusso, N., & Lindor, K. D. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2927-8 · Cited by 339
Self-citationLevi, S., Urbano-Ispizúa, Á., Gill, R., Thomas, D. M., Gilbertson, J. A., Foster, C., & Marshall, C. J. (1991) · PubMed · Cited by 328
Surgical Management of Hilar Cholangiocarcinoma
Hemming, A. W., Reed, A. I., Fujita, S., Foley, D. P., & Howard, R. J. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000160701.38945.82 · Cited by 324
Orthotopic models of cancer for preclinical drug evaluation
Bibby, M. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.021 · Cited by 315
Sudan, D., DeRoover, A., Chinnakotla, S., Fox, I., Shaw, B., McCashland, T., Sorrell, M., Tempero, M., & Langnas, A. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20812.x · Cited by 314
Surgical Treatment in Proximal Bile Duct Cancer: A Single-Center Experience
Pichlmayr, R., Weimann, A., Klempnauer, J., Oldhafer, K. J., Maschek, H., Tusch, G., & Ringe, B. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00007 · Cited by 309
Petrowsky, H., Wildbrett, P., Husarik, D. B., Hany, T. F., Tam, S., Jochum, W., & Clavien, P.-A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.009 · Cited by 305
Liver fluke-associated cholangiocarcinoma
Watanapa, P., & Watanapa, W. B. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02143.x · Cited by 303
Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival
Pitt, H. A., Nakeeb, A., Abrams, R. A., Coleman, J., Piantadosi, S., Yeo, C. J., Lillemoe, K. D., & Cameron, J. L. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00017 · Cited by 299
Corvera, C. U., Blumgart, L. H., Akhurst, T., DeMatteo, R. P., D’Angelica, M., Fong, Y., & Jarnagin, W. R. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.002 · Cited by 292
Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.
Sell, S., & Dunsford, H. A. (1989) · Europe PMC (PubMed Central) · Cited by 290
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.
Klempnauer, J., Ridder, G. J., von Wasielewski, R., Werner, M., Weimann, A., & Pichlmayr, R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.947 · Cited by 286
Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis
Jaiswal, M., LaRusso, N. F., & Gores, G. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.3.g626 · Cited by 278
Self-citationYu, C., Bruzek, L. M., Meng, X. W., Gores, G. J., Carter, C. A., Kaufmann, S. H., & Adjei, A. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208841 · Cited by 277
Self-citationLiver Transplantation for Unresectable Perihilar Cholangiocarcinoma
Heimbach, J., Gores, G., Haddock, M., Alberts, S., Nyberg, S., Ishitani, M., & Rosen, C. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828896 · Cited by 275
Self-citationPhotodynamic therapy of nonresectable cholangiocarcinoma
Ortner, M. E. J., Liebetruth, J., Schreiber, S., Hanft, M., Wruck, U., Fusco, V., Müller, J. M., Hörtnagl, H., & Lochs, H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70537-2 · Cited by 269
A Review and Update on Cholangiocarcinoma
Olnes, M. J., & Erlich, R. (2004) · Oncology · doi:10.1159/000077991 · Cited by 266
Shaib, Y. H., El-Serag, H. B., Nooka, A. K., Thomas, M., Brown, T. D., Patt, Y. Z., & Hassan, M. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01104.x · Cited by 258
Ricci, M. S., Kim, S.-H., Ogi, K., Plastaras, J. P., Ling, J., Wang, W., Jin, Z., Liu, Y. Y., Dicker, D. T., Chiao, P. J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.006 · Cited by 255
Liver Resection for Hilar and Peripheral Cholangiocarcinomas: A Study of 62 Cases
Madariaga, J. R., Iwatsuki, S., Todo, S., Lee, R. G., Irish, W., & Starzl, T. E. (1998) · Annals of Surgery · doi:10.1097/00000658-199801000-00011 · Cited by 254
Treatment of Hilar Cholangiocarcinoma (Klatskin Tumors) with Hepatic Resection or Transplantation
Iwatsuki, S., Todo, S., Marsh, W. J., Madariaga, J. R., Lee, R. G., Dvorchik, I., Fung, J. J., & Starzl, T. E. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00207-5 · Cited by 251
Nathan, H., Pawlik, T. M., Wolfgang, C. L., Choti, M. A., Cameron, J. L., & Schulick, R. D. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0282-0 · Cited by 245
Risk factors for biliary tract carcinogenesis
Chapman, R. W. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s308 · Cited by 244
“Natural History” of Unresected Cholangiocarcinoma: Patient Outcome After Noncurative Intervention
Farley, D. R., Weaver, A. L., & Nagorney, D. M. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.5.425 · Cited by 232
Isomoto, H., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Guicciardi, M. E., Frank, D. A., & Gores, G. J. (2005) · Hepatology · doi:10.1002/hep.20966 · Cited by 227
Self-citationSurgical Management of Cholangiocarcinoma
Jarnagin, W., & Shoup, M. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828895 · Cited by 226
Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.010 · Cited by 226
Self-citationWehbe, H., Henson, R., Meng, F., Mize-Berge, J., & Patel, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2130 · Cited by 224
Patel, T. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0389 · Cited by 224
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma
McMasters, K. M., Tuttle, T. M., Leach, S. D., Rich, T., Cleary, K. R., Evans, D. B., & Curley, S. A. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00203-1 · Cited by 220
Vascular effects of photodynamic therapy.
Krammer, B. E. (2001) · PubMed · Cited by 219
Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing
Isomoto, H., Mott, J. L., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Haan, S., & Gores, G. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.037 · Cited by 219
Self-citationHeimbach, J. K., Gores, G. J., Haddock, M. G., Alberts, S. R., Pedersen, R., Kremers, W., Nyberg, S. L., Ishitani, M. B., & Rosen, C. B. (2006) · Transplantation · doi:10.1097/01.tp.0000253551.43583.d1 · Cited by 213
Self-citationPhotodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik, M., & Dougherty, G. J. (1999) · PubMed · Cited by 211
Xu, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27282 · Cited by 207
Park, J., Tadlock, L., Gores, G. J., & Patel, T. (1999) · Hepatology · doi:10.1002/hep.510300522 · Cited by 206
Self-citationNarimatsu, H., Iwasaki, H., Nakayama, F., Ikehara, Y., Kudo, T., Nishihara, S., Sugano, K., Okura, H., Fujita, S., & Hirohashi, S. (1998) · PubMed · Cited by 205
Z'graggen, K., Rivera, J. A., Compton, C. C., Pins, M., Werner, J., Fernández-del Castillo, C., Rattner, D. W., Lewandrowski, K. B., Rustgi, A. K., & Warshaw, A. L. (1997) · Annals of Surgery · doi:10.1097/00000658-199710000-00010 · Cited by 200
Berr, F., Wiedmann, M., Tannapfel, A., Halm, U., Kohlhaw, K. R., Schmidt, F., Wittekind, C., Hauss, J., & Mössner, J. (2000) · Hepatology · doi:10.1002/hep.510310205 · Cited by 199
Tannapfel, A., Benicke, M., Katalinic, A., Uhlmann, D., Köckerling, F., Hauss, J., & Wittekind, C. (2000) · Gut · doi:10.1136/gut.47.5.721 · Cited by 193
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Self-citationBaron, T. H., Harewood, G. C., Rumalla, A., Pochron, N. L., Stadheim, L. M., Gores, G. J., Therneau, T. M., De Groen, P. C., Sebo, T. J., Salomao, D. R., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00006-0 · Cited by 192
Self-citationLiver cancer in Thailand. I. A case‐control study of cholangiocarcinoma
Parkin, D. M., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'abbé, K. A., & Wild, C. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480302 · Cited by 191
Endo, K., Yoon, B.-I., Pairojkul, C., Demetris, A. J., & Sirica, A. E. (2002) · Hepatology · doi:10.1053/jhep.2002.34435 · Cited by 188
Serum and Bile Markers for Cholangiocarcinoma
Nehls, O., Gregor, M., & Klump, B. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828891 · Cited by 180
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis
Siqueira, E., Schoen, R. E., Silverman, W., Martini, J., Rabinovitz, M., Weissfeld, J. L., Elmaagd, K. A., Madariaga, J. R., & Slivka, A. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125105 · Cited by 178
Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide.
Jaiswal, M., LaRusso, N. F., Nishioka, N., Nakabeppu, Y., & Gores, G. J. (2001) · PubMed · Cited by 177
Self-citationHepatolithiasis associated with cholangiocarcinoma
Kubo, S., Kinoshita, H., Hirohashi, K., & Hamda, H. (1995) · World Journal of Surgery · doi:10.1007/bf00294744 · Cited by 177
Date, K., Matsumoto, K., Kuba, K., Shimura, H., Tanaka, M., & Nakamura, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202231 · Cited by 176
Foo, M. L., Gunderson, L. L., Bender, C. E., & Buskirk, S. J. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00299-x · Cited by 175
Role of liver transplantation in the treatment of unresectable liver cancer
Pichlmayr, R., Weimann, A., Oldhafer, K. J., Schlitt, H. J., Klempnauer, J., Bornscheuer, A., Chavan, A., Schmoll, E., Lang, H., Tusch, G., et al. (1995) · World Journal of Surgery · doi:10.1007/bf00299775 · Cited by 166
Vestergaard, E. M., Hein, H. O., Meyer, H., Grunnet, N., Jørgensen, J. B., Wolf, H., & Orntoft, T. F. (1999) · PubMed · Cited by 164
COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells
Nzeako, U. C., Guicciardi, M. E., Yoon, J.-H., Bronk, S. F., & Gores, G. J. (2002) · Hepatology · doi:10.1053/jhep.2002.31774 · Cited by 163
Self-citationGoydos, J. S., Brumfield, A., Frezza, E., Booth, A., Lotze, M., & Carty, S. (1998) · Annals of Surgery · doi:10.1097/00000658-199803000-00012 · Cited by 160
FDG PET in the diagnosis of hilar cholangiocarcinoma
FRITSCHER-RAVENS, A., BOHUSLAVIZKI, K. H., BROERING, D. C., JENICKE, L., SCHÄFER, H., BUCHERT, R., ROGIERS, X., & CLAUSEN, M. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200112000-00002 · Cited by 160
Elevated serum levels of tumor marker CA19-9 in acute cholangitis
Albert, M. B., Steinberg, W. M., & Henry, J. P. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01536670 · Cited by 158
Targeting of the vascular system of solid tumours by photodynamic therapy (PDT)
Abels, C. (2004) · Photochemical & Photobiological Sciences · doi:10.1039/b314241h · Cited by 158
Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
Werneburg, N. W., Yoon, J., Higuchi, H., & Gores, G. J. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00536.2002 · Cited by 157
Self-citationDumoulin, F. L., Gerhardt, T., Fuchs, S., Scheurlen, C., Neubrand, M., Layer, G., & Sauerbruch, T. (2003) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(03)70021-2 · Cited by 152
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Hahn, S. A., Bartsch, D. K., Schroers, A., Galehdari, H., Becker, M. A., Ramaswamy, A., Schwarte‐Waldhoff, I., Maschek, H., & Schmiegel, W. (1998) · PubMed · Cited by 146
Cyclooxygenase-2 Promotes Human Cholangiocarcinoma Growth
Han, C. L., Leng, J., Demetris, A. J., & Wu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1086 · Cited by 143
Dose-Additive Carcinogenicity of a Defined Mixture of “Dioxin-like Compounds”
Walker, N. J., Crockett, P. W., Nyska, A., Brix, A. E., Jokinen, M. P., Sells, D. M., Hailey, J. R., Easterling, M., Haseman, J. K., Yin, M., et al. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.7351 · Cited by 136
Terada, T., Nakanuma, Y., & Sirica, A. E. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90229-5 · Cited by 133
Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells
Yoon, J., Gwak, G., Lee, H.-S., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.07.016 · Cited by 132
Self-citationYokomuro, S., Tsuji, H., Lunz, J. G., Sakamoto, T., Ezure, T., Murase, N., & Demetris, A. J. (2000) · Hepatology · doi:10.1053/jhep.2000.8535 · Cited by 129
Hepatolithiasis associated with cholangiocarcinoma
Su, C.-H., Ym, S., Lui, W., et al. (1997) · British journal of surgery · doi:10.1002/bjs.1800840717 · Cited by 124
Zhang, Z., Lai, G., & Sirica, A. E. (2004) · Hepatology · doi:10.1002/hep.20143 · Cited by 120
Fluorescence in situ hybridization in diagnostic cytology
Halling, K. C., & Kipp, B. R. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.04.015 · Cited by 116
Early detection and treatment of cholangiocarcinoma
Gores, G. J. (2000) · Liver Transplantation · doi:10.1053/jlts.2000.18688 · Cited by 116
Self-citationAishima, S., Taguchi, K., Sugimachi, K., Shimada, M., Sugimachi, K., & Tsuneyoshi, M. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.00353.x · Cited by 116
Weimann, A., Varnholt, H., Schlitt, H. J., Lang, H., Flemming, P., Hustedt, C., Tusch, G., & Raab, R. (2000) · British journal of surgery · doi:10.1046/j.1365-2168.2000.01532.x · Cited by 111
Ishimura, N., Bronk, S. F., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.055 · Cited by 110
Self-citationJimeno, A., Rubio‐Viqueira, B., Amador, M. L., Oppenheimer, D., Bouraoud, N., Kulesza, P., Sebastiani, V., Maitra, A., & Hidalgo, M. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3586 · Cited by 108
McLean, L. B., & Patel, T. C. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01350.x · Cited by 108
Review article: the modern diagnosis and therapy of cholangiocarcinoma
Malhi, H., & Gores, G. J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02900.x · Cited by 107
Self-citationTaïeb, J., Mitry, E., Boige, V., Artru, P., Ezenfis, J., Lecomte, T., Clavero-Fabri, M.-C., Vaillant, J.-N., Rougier, P. R., & Ducreux, M. P. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf201 · Cited by 101
Farazi, P. A., Zeisberg, M., Glickman, J. N., Zhang, Y., Kalluri, R., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4609 · Cited by 99
What Is the Current State-of-the-Art Imaging for Detection and Staging of Cholangiocarcinoma?
Slattery, J. M. A., & Sahani, D. V. (2006) · The Oncologist · doi:10.1634/theoncologist.11-8-913 · Cited by 98
Fava, G., Marucci, L., Glaser, S. S., Francis, H., Morrow, S. D., Benedetti, A., Alvaro, D., Venter, J. K., Meininger, C. J., Patel, T. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1470 · Cited by 98
Yoon, J., Canbay, A. E., Werneburg, N. W., Lee, S. P., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20125 · Cited by 96
Self-citationIsa, T., Tomita, S., Nakachi, A., Miyazato, H., Shimoji, H., Kusano, T., Muto, Y., & Furukawa, M. (2002) · PubMed · Cited by 93
Taniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 93
Self-citationInterleukin‐6 functions as an autocrine growth factor in a cholangiocarcinoma cell line
Okada, K., Shimizu, Y., Nambu, S., Higuchi, K., & Watanabe, A. (1994) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1994.tb01275.x · Cited by 92
Patt, Y. Z., Hassan, M. M., Lozano, R. D., Waugh, K. A., Hoque, A. M., Frome, A., Lahoti, S., Ellis, L. M., Vauthey, J., Curley, S. A., et al. (2001) · PubMed · Cited by 90
Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study
Nanashima, A., Yamaguchi, H., Shibasaki, S., Ide, N., Sawai, T., Tsuji, T., Hidaka, S., Sumida, Y., Nakagoe, T., & Nagayasu, T. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-004-1449-z · Cited by 90
Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.
Jones, D. V., Lozano, R. D., Hoque, A. M., Markowitz, A., & Patt, Y. Z. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2306 · Cited by 87
Dergham, S. T., Dugan, M. C., Kucway, R., Du, W., Kamarauskiene, D. S., Vaitkevicius, V. K., Crissman, J. D., & Sarkar, F. H. (1997) · International Journal of Pancreatology · doi:10.1007/bf02822384 · Cited by 86
Sirica, A. E., Zhang, Z., Lai, G., Asano, T., Shen, X., Ward, D. J., Mahatme, A., & DeWitt, J. L. (2007) · Hepatology · doi:10.1002/hep.22088 · Cited by 85
Ahn, E.-Y. E., Pan, G., Vickers, S. M., & McDonald, J. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10516 · Cited by 83
Boberg, K. M., Schrumpf, E., Bergquist, A. M., Broomé, U., Parés, A. R., Remotti, H. E., Schjolberg, A., Spurkland, A., & Clausen, O. P. F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80386-4 · Cited by 78
Wu, T., Han, C. L., Lunz, J. G., Michalopoulos, G. K., Shelhamer, J. H., & Demetris, J. A. (2002) · Hepatology · doi:10.1053/jhep.2002.34743 · Cited by 73
Tadlock, L., & Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.20676 · Cited by 71
Thamavit, W., Pairojkul, C., Tiwawech, D., Ito, M., Shirai, T., & Ito, N. (1993) · Carcinogenesis · doi:10.1093/carcin/14.11.2415 · Cited by 69
Alvaro, D., Macarri, G., Mancino, M. G., Marzioni, M., Bragazzi, M. C., Onori, P., Corradini, S. G., Invernizzi, P., Franchitto, A., Attili, A. F., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00003 · Cited by 69
横山, 幸., 梛野, 正., 湯浅, 典., 小田, 高., 新井, 利., 西尾, 秀., 江畑, 智., & 二村, 雄. (2006) · 日本外科学会雑誌 · Cited by 68
Ahrendt, S. A., Rashid, A., Chow, J. T., Eisenberger, C. F., Pitt, H. A., & Sidransky, D. (2000) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340070039 · Cited by 68
Extraordinarily Elevated Ca19-9 in Benign Conditions: A Case Report and Review of the Literature
Akdoğran, M., Şaşmaz, N., Kayhan, B., Bıyıkoğrlu, I., Dışıbeyaz, S., & Şahın, B. (2001) · Tumori Journal · doi:10.1177/030089160108700513 · Cited by 66
Intrahepatic cholangiocarcinoma: indication for transplantation
Pascher, A., Jonas, S., & Neuhaus, P. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-002-0731-9 · Cited by 66
Ishimura, N., Bronk, S. F., & Gores, G. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00539.2003 · Cited by 66
Self-citationTreatment Options for Hepatobiliary and Pancreatic Cancer
Alberts, S. R., Gores, G. J., Kim, G. P., Roberts, L. R., Kendrick, M. L., Rosen, C. B. B., Chari, S. T., & Martenson, J. A. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.5.628 · Cited by 63
Self-citationCholangiocarcinoma: Is transplantation an option? For whom?
Gores, G. J., Nagorney, D. M., & Rosen, C. B. B. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.003 · Cited by 63
Self-citationHepatic Resection in the Treatment of Hilar Cholangiocarcinoma
Nagorney, D. M., & Kendrick, M. L. (2006) · Advances in Surgery · doi:10.1016/j.yasu.2006.05.009 · Cited by 61
Nakajima, T., Takayama, T., Miyanishi, K., Nobuoka, A., Hayashi, T., Abe, T., Kato, J., Sakon, K., Naniwa, Y., Tanabe, H., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052696 · Cited by 61
Inhibition of Cholangiocarcinoma Growth by Tannic Acid
Marienfeld, C. B., Tadlock, L., Yamagiwa, Y., & Patel, T. C. (2003) · Hepatology · doi:10.1053/jhep.2003.50192 · Cited by 60
Wiedmann, M. W., Feisthammel, J., Blüthner, T., Tannapfel, A., Kamenz, T., Kluge, A., Mössner, J., & Caca, K. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000217433.48870.37 · Cited by 54
Yamagiwa, Y., Meng, F., & Patel, T. C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.015 · Cited by 53
Nomoto, K., Tsuneyama, K., Cheng, C., Takahashi, H., Hori, R., Murai, Y., & Takano, Y. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2005.10.011 · Cited by 49
Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers
Itoi, T., Shinohara, Y., Takeda, K., Takei, K., Ohno, H., Ohyashiki, K., Yahata, N., Ebihara, Y., & Saito, T. (2000) · Gastrointestinal Endoscopy · doi:10.1067/mge.2000.108303 · Cited by 48
Lai, G., Radaeva, S., Nakamura, T., & Sirica, A. E. (2000) · Hepatology · doi:10.1053/jhep.2000.8108 · Cited by 47
Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma
Tanaka, S., Sugimachi, K., Shirabe, K., Shimada, M., Wands, J. R., & Sugimachi, K. (2000) · Hepatology · doi:10.1053/jhep.2000.9716 · Cited by 44
Technology Insight: photodynamic therapy for cholangiocarcinoma
Ortner, M.-A., & Dorta, G. O. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0543 · Cited by 34
Ozaki, S., Harada, K., Sanzen, T., Watanabe, K., Tsui, W. M. S., & Nakanuma, Y. (1999) · Hepatology · doi:10.1002/hep.510300419 · Cited by 31
Single-Agent Gemcitabine for Biliary Tract Cancers
Kiba, T., Nishimura, T., Matsumoto, S., et al. (2006) · Oncology · doi:10.1159/000098109 · Cited by 23
Hepatic MR Imaging Using Ferumoxides
Raman, S. S., Lu, D., Chen, S. C., et al. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.4.1770807 · Cited by 22
Iki, K., Tsujiuchi, T., Majima, T., Sakitani, H., Tsutsumi, M., Takahama, M., Yoshimoto, M., Nakae, D., Tsunoda, T., & Konishi, Y. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00148-7 · Cited by 10
Cited by
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Self-citationPathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Self-citationPrimary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Khan, S. A., Davidson, B. R., Goldin, R. D., Heaton, N., Karani, J., Pereira, S. P., Rosenberg, W. M. C., Tait, P., Taylor-Robinson, S. D., Thillainayagam, A. V., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301748 · Cited by 797
Clinical diagnosis and staging of cholangiocarcinoma
Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.131 · Cited by 747
Self-citation
Metadata
- Authors
- Blechacz, B., & Gores, G. J.
- Venue
- Hepatology
- Published
- 2008-07
- Volume
- 48
- Issue
- 1
- Pages
- 308-321
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2035515971
- Cited by
- 681
- References
- 154
- FWCI
- 39.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.